View the LAKAS TABLET 10 MG registration information details.
Back to drug list
ItemsDrug Registration information
ID1227
No1227
Brand NameLAKAS TABLET 10 MG
IngredientsMONTELUKAST SODIUM EQ. TO MONTELUKAST 10 MG
Dosage FormTABLET
Primary PackagingALU-ALU
Storage
Shelf Life2 YEARS
Pack Size1 X 10'S/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF ASTHMA AS ADD-ON THERAPY IN ADULTS AND CHILDREN WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA-AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionOFF WHITE COLORED ROUND SHAPED BICONVEXED TABLETS PLAIN ON BOTH SIDE
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerFOCUS & RULZ PHARMACEUTICALS (PVT) LTD
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 4667/19
FDD Registration Date22/06/2024
Expiry Date21/06/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA